Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Equity

v3.25.1
Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
April 2023 Private Placement [Member]
Common Stock [Member]
April 2023 Private Placement [Member]
Additional Paid-in Capital [Member]
April 2023 Private Placement [Member]
Retained Earnings [Member]
April 2023 Private Placement [Member]
AOCI Attributable to Parent [Member]
April 2023 Private Placement [Member]
Parent [Member]
April 2023 Private Placement [Member]
Noncontrolling Interest [Member]
April 2023 Private Placement [Member]
Stock Based Compensation Warrants [Member]
Common Stock [Member]
Stock Based Compensation Warrants [Member]
Additional Paid-in Capital [Member]
Stock Based Compensation Warrants [Member]
Retained Earnings [Member]
Stock Based Compensation Warrants [Member]
AOCI Attributable to Parent [Member]
Stock Based Compensation Warrants [Member]
Parent [Member]
Stock Based Compensation Warrants [Member]
Noncontrolling Interest [Member]
Stock Based Compensation Warrants [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2022                             14,402            
Balance at Dec. 31, 2022                             $ 1 $ 56,963 $ (31,147) $ (41) $ 25,776 $ 0 $ 25,776
Issuance of common stock related to April offering (in shares) 3,429                                        
Issuance of common stock related to April offering $ 1 $ 5,999 $ 0 $ 0 $ 6,000 $ 0 $ 6,000                            
Issuance of common stock related to exercise of warrants (in shares)                             105            
Issuance of common stock related to exercise of warrants                             $ 0 184 0 0 184 0 184
Issuance of common stock related to restricted stock award (in shares)                             789            
Issuance of common stock related to restricted stock award                             $ 0 2,468 0 0 2,468 300 2,768
Stock-based compensation               $ 0 $ 32 $ 0 $ 0 $ 32 $ 0 $ 32 0 1,524 0 0 1,524   2,576
Stock-based compensation in connection with options granted                                       1,052  
Acquisition of subsidiary and noncontrolling interests                             0 0 0 0 0 23,180 23,180
Comprehensive loss                             0 0 0 (22) (22) 0 (22)
Net loss                             $ 0 0 (3,778) 0 (3,778) (8,629) (12,407)
Balance (in shares) at Dec. 31, 2023                             18,725            
Balance at Dec. 31, 2023                             $ 2 67,170 (34,925) (63) 32,184 15,903 48,087
Issuance of common stock related to exercise of warrants (in shares)                             48            
Issuance of common stock related to exercise of warrants                             $ 0 85 0 0 85 0 85
Issuance of common stock related to restricted stock award (in shares)                             220            
Issuance of common stock related to restricted stock award                             $ 0 772 0 0 772 405 1,177
Stock-based compensation                             0 455 0 0 455 0 455
Comprehensive loss                             0 0 0 (3) (3) 0 (3)
Net loss                             $ 0 0 (14,025) 0 (14,025) (9,100) (23,125)
Stock-based compensation (in shares)                             0            
Capital contribution of noncontrolling interests                             $ 0 0 0 0 0 122 122
Issuance of common stock related to Progressive Care Merger (in shares)                             6,970            
Issuance of common stock related to Progressive Care Merger                             $ 1 7,215 0 0 7,216 (7,216) 0
Balance (in shares) at Dec. 31, 2024                             25,963            
Balance at Dec. 31, 2024                             $ 3 $ 75,697 $ (48,950) $ (66) $ 26,684 $ 114 $ 26,798